Dr. Kovalenko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1401 Spanos CT Ste 230
Modesto, CA 95355Phone+1 209-550-4720
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Obstetrics and Gynecology, 2020 - 2024
- Case Western Reserve University School of MedicineClass of 2020
- Case Western Reserve UniversityBA, Biology, International Studies, cum laude, 2012 - 2016
Certifications & Licensure
- CA State Medical License 2024 - 2026
Awards, Honors, & Recognition
- Honors with Distinction in Research Case Western Reserve University School of Medicine, 2020
Publications & Presentations
PubMed
- 73 citationsCompassionate Use of Remdesivir in Pregnant Women with Severe Covid-19.Richard M. Burwick, Sigal Yawetz, Kathryn E. Stephenson, Ai-ris Y. Collier, Pritha Sen
Clinical Infectious Diseases. 2020-10-08 - 27 citationsThe miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer.Anil Belur Nagaraj, Matthew Knarr, Sreeja C. Sekhar, R. Shae Connor, Peronne Joseph
Cancer Research. 2021-04-15 - 150 citationsCritical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.Anil Belur Nagaraj, Peronne Joseph, Olga Kovalenko, Sareena Singh, Amy Armstrong
Oncotarget. 2015-09-15
Journal Articles
- The miR–181a–SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in OvariaBelur Nagaraj, A, Knarr M, Sekhar S, Connor R, Joseph P, Kovalenko O, Fleming A, Surti A, Nurmemmedov E, Beltrame L Marchini S, Kahn M, Difeo A, Cancer Research, 4/2021
- Hyperhomocysteinemia and Pulmonary Embolism in a Young MaleKovalenko O, Kassem AN, Jenkins M, Cureus, 2020
- Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.Belur Nagaraj A, Joseph P, Kovalenko O, Wang Q, Xu R, DiFeo A, Gynecol Oncol, 2018
- Join now to see all
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: